HOME >> MEDICINE >> NEWS
Synthetic progestin damages, estrogen protects blood vessels in animal model

TAMPA (11 Dec 2003) -- Synthetic progestins may be the major cause of harmful side effects reported with hormone replacement therapy. University of South Florida researchers used a novel imaging technique to show that progestins caused toxicity while natural progesterone and estrogen did not show toxicity to blood vessels in live animals.

"Our findings can lead to the development and screening of synthetic hormones to find a safe progestin that will ultimately give women safer options than are currently available for hormone replacement therapy," said Tom Thomas, MD, PhD, co-principal investigator and lead author of the study published today in Climacteric, the Journal of the International Menopause Society.

"This is experimental evidence that supports scientists who believe estrogen with the right formulation is good for some women, depending on their other risk factors."

The novel imaging technique was developed by Thomas and Johannes Rhodin, MD, PhD, co-principal investigator. It took three years for Thomas and Rhodin to combine video microscopy with fluorescence and electron microscopy. By labeling blood cells with a fluorescent tag, the team observed blood flow, blood vessel structure and activities of various blood cells in real time in a live animal. After one dose of medroxy progesterone acetate (MPA), the most widely used synthetic progestin in estrogen prepaparations and oral contraceptives, the rats had visible damage to the periphery and brain blood vessels, endothelial and smooth muscle damage, inflammation and blood clot formation and impeded blood flow.

These vascular reactions to synthetic progestin can lead to increases in heart attacks, blood clots, strokes and dementia--problems that were observed in the Women's Health Initiative," Thomas said.

The USF researchers' findings may shed light on the current reassessment of the National Institute of Health-sponsored Women's Health Initiative.

Using the sa
'"/>

Contact: Marissa Emerson
memerson@hsc.usf.edu
813-974-3300
University of South Florida Health
11-Dec-2003


Page: 1 2

Related medicine news :

1. Synthetic marijuana reduces agitation in patients with Alzheimers
2. Synthetic marijuana compound reduces agitation, improves appetite in Alzheimers patients
3. Synthetic rubber kills germs on contact
4. Views Of Tamoxifen And Synthetic Estrogen In Action Provide Clues For Designing Better Drugs
5. UCSF Study In Rats Suggests Synthetic Drug Mimicking Marijuana Might Be Used To Treat Pain
6. "Green Chemistry" Cleans Up Environment And Renders Synthetic Drugs
7. Synthetic Detergent Found To Fight Multi-Drug Resistance
8. Estrogren plus progestin decreases colorectal cancer in postmenopausal woman
9. High estrogen/progestin levels may reduce asthma severity, say Pittsburgh researchers
10. Changing chemistry helps explain estrogen threat to the heart
11. Use of estrogen therapy may increase risk for gallbladder disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ... Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, ... guideline updates for the primary prevention of cardiovascular diseases during the 15th ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun ... NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is ... is geared towards children of all ages; it is a non-competitive, non-timed event, which ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
Breaking Medicine Technology:
Cached News: